Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis.
Academic Article
Publication Date:
2015
Iris type:
1.1 Articolo in rivista
List of contributors:
Montalban, X; Comi, Giancarlo; Antel, J; O'Connor, P; de Vera, A; Cremer, M; Sfikas, N; von Rosenstiel, P; Kappos, L.
Published in: